Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans

Authors:

Top Cited Papers
Open Access
Abstract
No abstract available
Funding Information
  • Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen
  • Bundesministerium für Forschung, Technologie und Raumfahrt
  • Institute of Space and Astronautical Science
  • University of California, Davis (T32 GM144303)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK139663)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK139565)

This publication has 55 references indexed in Scilit: